Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Intima Bioscience, Inc.
NantCell, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Palleon Pharmaceuticals, Inc.
Hoffmann-La Roche
Esperas Pharma Inc.
NuCana plc
Intensity Therapeutics, Inc.
PureTech
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
NantBioScience, Inc.
Augusta University
National Institutes of Health Clinical Center (CC)
Klus Pharma Inc.
H. Lee Moffitt Cancer Center and Research Institute
Gilead Sciences
Gilead Sciences
University of Arkansas
Roswell Park Cancer Institute
University of Louisville
SillaJen, Inc.
Isofol Medical AB
Jonsson Comprehensive Cancer Center
Lumos Pharma
Brown University
University of Leicester
Stanford University
Surgimab
Swiss Cancer Institute
Icahn School of Medicine at Mount Sinai
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
Medical University of South Carolina
MediGene
Precision Biologics, Inc
University of British Columbia
Memorial Sloan Kettering Cancer Center
Medical University of Vienna
Corporal Michael J. Crescenz VA Medical Center
National Research Council, Spain
National Cancer Institute (NCI)
University Hospital, Basel, Switzerland
Arya, Vijaypal, M.D., P.C.
National Cancer Institute (NCI)
Amgen
Amgen
University of Chicago
Memorial Sloan Kettering Cancer Center